InvestorsHub Logo
Followers 21
Posts 154
Boards Moderated 0
Alias Born 05/27/2008

Re: None

Thursday, 02/27/2014 7:06:49 PM

Thursday, February 27, 2014 7:06:49 PM

Post# of 403033
Currently, an antibiotic called Cefazolin (Ancef, Kefzol), is prophylactically given prior to the start of almost every single surgical procedure to prevent surgical site infections (SSIs).

[Cefazolin is a first-generation cephalosporin that arrests bacterial cell wall synthesis and thus inhibits bacterial growth. This antibiotic is routinely used as the prophylactic drug of choice becasue it is primarily active against skin flora, including Staphylococcus aureus, and therefore a logical choice to prevent SSIs. Typical dosing is every 4 to 6 hours due to the pharmacodynamics and pharmacokinetics of the drug.]

I raise the above points because as a clinician treating patients in the peri-operative, I am always hopeful that a better "Ancef" is coming our way.

With the current trial of Brilacidin already underway, I am extremely excited and optimistic that this new drug may have potential and uses that far exceed many of our wildest imaginations. The market potential can be truly astronomical!!

As always, I am LONG CTIX!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News